{
  "main_header": {
    "sid": 10039457,
    "name": "Onyx Biotec",
    "stock_name": "Onyx Biotec",
    "full_name": "Onyx Biotec Ltd",
    "name_url": "stocks-analysis/onyx-biotec",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.10",
    "chg": -4.9,
    "chgp": "-13.24%",
    "dir": -1,
    "prev_price": "37.00",
    "mcapval": "67.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "ONYX",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0WVU01018",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": 44000,
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/onyx-biotec-10039457-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3703909",
        "imagepath": "",
        "date": "2025-11-15 00:18:00",
        "description": "As of 14-Nov, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 38.50, which represents a decrease of 4.45 or 10.36%. The stock has underperformed its sector by 10.73% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 67.03% compared to the 5-day average. The stock has also shown poor performance over various periods, with a year-to-date decline of 35.29%, indicating ongoing challenges for the company.\n\nIn the broader market context, the Sensex has shown a positive return of 1.64% over the past week and 3.04% over the past month, contrasting sharply with Onyx Biotec's declines of 4.11% and 8.33% in the same periods. This suggests that while the overall market is performing well, Onyx Biotec is struggling significantly. The lack of avail..."
      },
      {
        "title": "How has been the historical performance of Onyx Biotec?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-onyx-biotec-3699883",
        "imagepath": "",
        "date": "2025-11-13 23:54:11",
        "description": "Answer:\nThe historical performance of Onyx Biotec shows a consistent growth trajectory in net sales and profitability over the past three fiscal years.\n\nBreakdown:\nOnyx Biotec's net sales increased from 39.48 Cr in Mar'23 to 53.75 Cr in Mar'24, and further to 61.95 Cr in Mar'25, indicating a strong upward trend. Total operating income mirrored this growth, reaching 61.95 Cr in Mar'25. The company's total expenditure also rose, from 35.03 Cr in Mar'23 to 51.61 Cr in Mar'25, primarily driven by an increase in raw material costs and employee expenses. Operating profit (PBDIT) improved significantly from 4.58 Cr in Mar'23 to 11.51 Cr in Mar'25, with a corresponding increase in the operating profit margin from 11.27% to 16.69%. Profit before tax followed suit, rising from 2.55 Cr in Mar'23 to 6.48 Cr in Mar'25, while profit after tax also saw a substantial increase from 1.84 Cr to 4.95 Cr during the same period...."
      },
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3695490",
        "imagepath": "",
        "date": "2025-11-13 00:27:09",
        "description": "As of 12-Nov, Onyx Biotec Ltd's stock price is currently at 42.80, reflecting an increase of 0.8, or 1.9%. The stock has shown a strong performance today, outperforming its sector by 0.92%. Additionally, the delivery volume has significantly increased by 1223.53% compared to the 5-day average, indicating rising investor participation. While the stock is higher than its 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has gained 7.27%, which is notably higher than the Sensex's increase of 1.09%, suggesting a positive momentum in the short term. However, the year-to-date performance shows a decline of 28.07%, contrasting with the Sensex's gain of 9.44%.\n\nIn the broader market context, Onyx Biotec's recent rise can be attributed to its strong short-term performance relative to the benchmark, as it has outperformed the Sensex over..."
      },
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3654083",
        "imagepath": "",
        "date": "2025-10-29 02:20:39",
        "description": "As of 28-Oct, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 40.50, which represents a decrease of 2.0 or 4.71%. The stock has underperformed its sector by 4.45% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has fallen by 5.81%, and in the last month, it has decreased by 9.90%. Despite a significant increase in delivery volume by 1364.29% against the 5-day average, there are no positive or negative factors available to provide further context on the stock's recent movement.\n\nBroader Market Context: In comparison to the benchmark Sensex, which has increased by 0.26% over the past week and 5.20% over the past month, Onyx Biotec's performance has been notably poor. Year-to-date, while the Sensex has gained 9.69%, Onyx Biotec has seen a substantial decline of 31.93%. This stark contrast highlights the stock's..."
      },
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3642275",
        "imagepath": "",
        "date": "2025-10-24 00:16:42",
        "description": "As of 23-Oct, Onyx Biotec Ltd's stock price is rising, currently at 44.30, reflecting an increase of 1.3 or 3.02%. The stock has outperformed its sector today by 3.23%, and while it is higher than its 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a positive return of 5.48%, although it has declined by 3.28% over the past month and has a year-to-date drop of 25.55%. There is no information available regarding positive or negative factors that could specifically explain the stock's recent movement.\n\nIn the broader market context, the Sensex has increased by 1.20% over the past week, indicating that Onyx Biotec's short-term performance is significantly better than the benchmark. However, the stock's longer-term performance remains concerning, with a year-to-date decline that contrasts sharply with the Sensex's gain o..."
      },
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3636411",
        "imagepath": "",
        "date": "2025-10-20 23:23:46",
        "description": "As of 20-Oct, Onyx Biotec Ltd's stock price is currently at Rs 36.30, reflecting a decline of Rs 6.1 or 14.39%. The stock has significantly underperformed, with a one-week return of -16.26% and a one-month return of -19.78%. It is also trading below all key moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, just 2.2% away from Rs 35.5. Despite a rise in delivery volume by 33.33% on October 17, which suggests increased investor participation, there are no positive factors identified in the provided data to counterbalance the negative performance.\n\nIn the broader market context, the Sensex has shown resilience with a one-week gain of 2.44% and a one-month gain of 2.04%, contrasting sharply with Onyx Biotec's poor performance. This indicates that while the overall market is experiencing growth, Onyx Biotec is struggling significantly, with a year-to-date decline o..."
      },
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3580973",
        "imagepath": "",
        "date": "2025-09-30 00:04:37",
        "description": "As of 29-Sep, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at Rs 42.40, which reflects a decrease of Rs 2.55 or 5.67%. The stock has underperformed its sector by 5.81% today and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, the stock is close to its 52-week low, being only 2.59% away from Rs 41.3. Over the past week, the stock has dropped by 7.42%, and year-to-date, it has seen a significant decline of 28.74%. There is a notable decrease in investor participation, with delivery volume on September 26 falling by 90.08% compared to the 5-day average, indicating a lack of interest among investors.\n\nIn the broader market context, the Sensex has shown a decline of 2.25% over the past week, which is less severe than Onyx Biotec's performance. While the benchmark has gained 0.85% over the past month, Onyx Biote..."
      },
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3568982",
        "imagepath": "",
        "date": "2025-09-24 23:57:11",
        "description": "As of 24-Sep, Onyx Biotec Ltd is currently priced at 45.80, showing no change (0.00%). The stock has underperformed in the past week, declining by 6.53%, and has also seen a significant year-to-date drop of 23.03%. Today's performance indicates that the stock has outperformed its sector by 0.45%, but it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 87.95% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.\n\nIn the broader market context, Onyx Biotec's short-term performance has been significantly worse than the benchmark, with the Sensex only declining by 1.08% over the past week and gaining 5.97% year-to-date. This st..."
      },
      {
        "title": "Why is Onyx Biotec falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-onyx-biotec-fallingrising-3562942",
        "imagepath": "",
        "date": "2025-09-24 00:14:44",
        "description": "As of 23-Sep, Onyx Biotec Ltd is currently priced at 45.80, with no change in price, reflecting a 0.00% movement. The stock has underperformed in the short term, with a 1-week decline of 6.53% and a 1-month decline of 5.76%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Investor participation has also decreased significantly, with a delivery volume drop of 87.95% compared to the 5-day average, suggesting reduced interest in the stock. There is no information available regarding positive or negative factors that could influence the stock's recent movement.\n\nIn the broader market context, Onyx Biotec's performance contrasts sharply with the Sensex, which has seen a slight decline of only 0.28% over the past week and a gain of 1.20% over the past month. Year-to-date, Onyx Biotec has experienced a substantial decline of 23.0..."
      }
    ],
    "total": 34,
    "sid": "10039457",
    "stock_news_url": "https://www.marketsmojo.com/news/onyx-biotec-10039457"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Onyx Biotec falling/rising?

2025-11-15 00:18:00

As of 14-Nov, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 38.50, which represents a decrease of 4.45 or 10.36%. The stock has underperformed its sector by 10.73% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 67.03% compared to the 5-day average. The stock has also shown poor performance over various periods, with a year-to-date decline of 35.29%, indicating ongoing challenges for the company. In the broader market context, the Sensex has shown a positive return of 1.64% over the past week and 3.04% over the past month, contrasting sharply with Onyx Biotec's declines of 4.11% and 8.33% in the same periods. This suggests that while the overall market is performing well, Onyx Biotec is struggling significantly. The lack of avail...

Read More

How has been the historical performance of Onyx Biotec?

2025-11-13 23:54:11

Answer: The historical performance of Onyx Biotec shows a consistent growth trajectory in net sales and profitability over the past three fiscal years. Breakdown: Onyx Biotec's net sales increased from 39.48 Cr in Mar'23 to 53.75 Cr in Mar'24, and further to 61.95 Cr in Mar'25, indicating a strong upward trend. Total operating income mirrored this growth, reaching 61.95 Cr in Mar'25. The company's total expenditure also rose, from 35.03 Cr in Mar'23 to 51.61 Cr in Mar'25, primarily driven by an increase in raw material costs and employee expenses. Operating profit (PBDIT) improved significantly from 4.58 Cr in Mar'23 to 11.51 Cr in Mar'25, with a corresponding increase in the operating profit margin from 11.27% to 16.69%. Profit before tax followed suit, rising from 2.55 Cr in Mar'23 to 6.48 Cr in Mar'25, while profit after tax also saw a substantial increase from 1.84 Cr to 4.95 Cr during the same period....

Read More

Why is Onyx Biotec falling/rising?

2025-11-13 00:27:09

As of 12-Nov, Onyx Biotec Ltd's stock price is currently at 42.80, reflecting an increase of 0.8, or 1.9%. The stock has shown a strong performance today, outperforming its sector by 0.92%. Additionally, the delivery volume has significantly increased by 1223.53% compared to the 5-day average, indicating rising investor participation. While the stock is higher than its 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has gained 7.27%, which is notably higher than the Sensex's increase of 1.09%, suggesting a positive momentum in the short term. However, the year-to-date performance shows a decline of 28.07%, contrasting with the Sensex's gain of 9.44%. In the broader market context, Onyx Biotec's recent rise can be attributed to its strong short-term performance relative to the benchmark, as it has outperformed the Sensex over...

Read More

Why is Onyx Biotec falling/rising?

2025-10-29 02:20:39

As of 28-Oct, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 40.50, which represents a decrease of 2.0 or 4.71%. The stock has underperformed its sector by 4.45% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has fallen by 5.81%, and in the last month, it has decreased by 9.90%. Despite a significant increase in delivery volume by 1364.29% against the 5-day average, there are no positive or negative factors available to provide further context on the stock's recent movement. Broader Market Context: In comparison to the benchmark Sensex, which has increased by 0.26% over the past week and 5.20% over the past month, Onyx Biotec's performance has been notably poor. Year-to-date, while the Sensex has gained 9.69%, Onyx Biotec has seen a substantial decline of 31.93%. This stark contrast highlights the stock's...

Read More

Why is Onyx Biotec falling/rising?

2025-10-24 00:16:42

As of 23-Oct, Onyx Biotec Ltd's stock price is rising, currently at 44.30, reflecting an increase of 1.3 or 3.02%. The stock has outperformed its sector today by 3.23%, and while it is higher than its 5-day and 20-day moving averages, it remains below the 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has shown a positive return of 5.48%, although it has declined by 3.28% over the past month and has a year-to-date drop of 25.55%. There is no information available regarding positive or negative factors that could specifically explain the stock's recent movement. In the broader market context, the Sensex has increased by 1.20% over the past week, indicating that Onyx Biotec's short-term performance is significantly better than the benchmark. However, the stock's longer-term performance remains concerning, with a year-to-date decline that contrasts sharply with the Sensex's gain o...

Read More

Why is Onyx Biotec falling/rising?

2025-10-20 23:23:46

As of 20-Oct, Onyx Biotec Ltd's stock price is currently at Rs 36.30, reflecting a decline of Rs 6.1 or 14.39%. The stock has significantly underperformed, with a one-week return of -16.26% and a one-month return of -19.78%. It is also trading below all key moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, just 2.2% away from Rs 35.5. Despite a rise in delivery volume by 33.33% on October 17, which suggests increased investor participation, there are no positive factors identified in the provided data to counterbalance the negative performance. In the broader market context, the Sensex has shown resilience with a one-week gain of 2.44% and a one-month gain of 2.04%, contrasting sharply with Onyx Biotec's poor performance. This indicates that while the overall market is experiencing growth, Onyx Biotec is struggling significantly, with a year-to-date decline o...

Read More

Why is Onyx Biotec falling/rising?

2025-09-30 00:04:37

As of 29-Sep, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at Rs 42.40, which reflects a decrease of Rs 2.55 or 5.67%. The stock has underperformed its sector by 5.81% today and is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, the stock is close to its 52-week low, being only 2.59% away from Rs 41.3. Over the past week, the stock has dropped by 7.42%, and year-to-date, it has seen a significant decline of 28.74%. There is a notable decrease in investor participation, with delivery volume on September 26 falling by 90.08% compared to the 5-day average, indicating a lack of interest among investors. In the broader market context, the Sensex has shown a decline of 2.25% over the past week, which is less severe than Onyx Biotec's performance. While the benchmark has gained 0.85% over the past month, Onyx Biote...

Read More

Why is Onyx Biotec falling/rising?

2025-09-24 23:57:11

As of 24-Sep, Onyx Biotec Ltd is currently priced at 45.80, showing no change (0.00%). The stock has underperformed in the past week, declining by 6.53%, and has also seen a significant year-to-date drop of 23.03%. Today's performance indicates that the stock has outperformed its sector by 0.45%, but it is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. Additionally, there has been a notable decrease in investor participation, with delivery volume falling by 87.95% compared to the 5-day average. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement. In the broader market context, Onyx Biotec's short-term performance has been significantly worse than the benchmark, with the Sensex only declining by 1.08% over the past week and gaining 5.97% year-to-date. This st...

Read More

Why is Onyx Biotec falling/rising?

2025-09-24 00:14:44

As of 23-Sep, Onyx Biotec Ltd is currently priced at 45.80, with no change in price, reflecting a 0.00% movement. The stock has underperformed in the short term, with a 1-week decline of 6.53% and a 1-month decline of 5.76%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Investor participation has also decreased significantly, with a delivery volume drop of 87.95% compared to the 5-day average, suggesting reduced interest in the stock. There is no information available regarding positive or negative factors that could influence the stock's recent movement. In the broader market context, Onyx Biotec's performance contrasts sharply with the Sensex, which has seen a slight decline of only 0.28% over the past week and a gain of 1.20% over the past month. Year-to-date, Onyx Biotec has experienced a substantial decline of 23.0...

Read More

View All News